中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
International Journal of Surgery Case Reports 2016

Synchronous thymoma and oligodendroglioma: A rare association.

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
Mohammad Vaziri
Kamelia Rad

关键词

抽象

BACKGROUND

Patients with thymoma are found to have another systemic illness and a broadly increased risk for secondary malignancies. We present the case of a 53-year-old female patient who harbored two synchronous primary malignant neoplasms-an anaplastic oligodendroglioma of the right frontal lobe and an anterior mediastinal thymoma.

METHODS

A 53-year-old female patient presented in her first hospital admission with nausea, chest pain and non-pulsatile bitemporal headache. Continued headache and nausea along with negative cardiac findings prompted radiological evaluation including chest CT scan and brain CT scan which revealed simultaneous anterior mediastinal mass and frontal lobe calcification respectively. The patient underwent craniotomy and the pathological diagnosis was anaplastic oligodendriglioma. The anterior mediastinal tumor resection was performed three months later, while the patient had no newly onset of any symptoms necessitating more investigation.

CONCLUSIONS

Multiple primary malignancies have been diagnosed by the following criteria: each tumor must have an obvious picture of malignancy, each must be separate and discrete and the probability that one was a metastatic lesion from the other must be excluded. Treatment strategies in cases of double malignancy involve treating the malignancy that is more advanced first. In our case we concluded that synchronous double malignancy can be treated successfully according to the above mentioned criteria.

CONCLUSIONS

Clinicians should be aware of the possibility of synchronous malignancies in order to use screening procedures in patients with reported increased risk of double malignancy. Such clinical alertness may lead to a better outcome for double primary tumor cases.

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge